NBY
Novabay Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.21
-0.06 ▼ -4.72%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$1.21
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -7.43 | Insider Own | 95.11% | Shs Outstand | 0.03B | Perf Week | -12.95% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -63.44% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | - | Inst Own | 5.45% | Short Float | 72.35% | Perf Quarter | -90% |
| Income | -0.01B | P/S | 11.17 | EPS this Y | - | Inst Trans | - | Short Ratio | 1.8 | Perf Half Y | -87.55% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -215.92% | Short Interest | 0.93M | Perf YTD | -95.71% |
| Book/sh | -2.23 | P/C | 13.68 | EPS past 3/5Y | 76.04% 66.43% | ROE | -587.58% | 52W High | -98.79% ($99.75) | Perf Year | -42.93% |
| Cash/sh | 0.09 | P/FCF | - | Sales past 3/5Y | -1.4% 8.19% | ROIC | -395.68% | 52W Low | 9.01% ($1.11) | Perf 3Y | -99.3% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 95.81% | Gross Margin | 51.27% | Volatility(W/M) | 14.6% 21.86% | Perf 5Y | -99.97% |
| Dividend TTM | - | EV/Sales | 12.22 | Sales Y/Y TTM | -74.73% | Oper. Margin | -249.12% | ATR (14) | 1.56 | Perf 10Y | -99.98% |
| Dividend Ex-Date | 2025/9/30 | Quick Ratio | 1.98 | EPS Q/Q | 63.18% | Profit Margin | -285.09% | RSI (14) | 33.82 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.98 | Sales Q/Q | -78.66% | SMA20 | -30.47% ($1.74) | Beta | 0.32 | Target Price | $4.25 |
| Payout | - | Debt/Eq | 0.6 | Earnings | 11000000 | SMA50 | -93.29% ($18.03) | Rel Volume | 0.36 | Prev Close | $1.27 |
| Employees | 14 | LT Debt/Eq | 0.25 | EPS/Sales Surpr. | - | SMA200 | -86.45% ($8.93) | Avg Volume(3M) | 0.52M | Price | $1.21 |
| IPO | 2007/10/26 | Option/Short | No/Yes | Trades | 940 | Volume | 186,801 | Change | -4.72% |
뉴스 로딩 중...